EARLY Routine Catheterization After Alteplase Fibrinolysis vs. PPCI in ST-Segment-Elevation MYOcardial Infarction

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 344 participants.

Also called NCT01930682

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 344 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01930682
Other papers using this trial's data
  • Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction) Circulation, 2017-10-17 DOI, PubMed 28844990 PubMed links an erratum for this paper. Erratum: PMID 29440206

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01930682. Randomized; single masking; primary purpose treatment. Start 2014-01-13 (actual); primary completion 2016-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
EARLY Routine Catheterization After Alteplase Fibrinolysis vs. PPCI in ST-Segment-Elevation MYOcardial Infarction
Acronym
EARLY-MYO
Condition
Acute ST-segment Elevation Myocardial Infarction
Intervention (Drug)
Alteplase
Intervention (Procedure)
Early post-fibrinolytic catheterisation
Intervention (Procedure)
Primary PCI (percutaneous coronary intervention)
Lead sponsor
RenJi Hospital (class: other)

Record details

Record id
cardio:ct-nct01930682
Content hash
f49f1812f3908e15d5cb791e7abcd523b490e11f716342813ceef6ed7e4e60a4